COSA 2022: Real-Time Risk Score IDs Cancer Patients Benefiting From Targeted Thromboprophylaxis
TARGET-TP score based on fibrinogen and D-dimer levels substantially mitigated thromboembolic risk without safety concerns
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.